Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

172292

	registered interest
	date	06/01/2015
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Funerals
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, what steps he is taking to ensure that funerals are affordable.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	219784
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>As the funeral sector is subject to consumer regulation and many crematoriums and burial plots are the responsibility of local authorities my department cannot influence funeral costs. However, it does operate the Social Fund Funeral Payment scheme which continues to provide help towards a simple, respectful, low-cost funeral for those who are eligible. In 2013/14, over 33,000 awards were made worth £44.4 million, with an average award of £1,347.</p><p> </p><p>This Government has extended the Budgeting Loan provision to include funeral expenses. This helps where a deposit is required up front, or towards the balance of costs that a Social Fund Funeral Payment cannot meet.</p><p> </p><p>This Government has also introduced the measure whereby any arrears of benefit, which were due to the deceased at date of death, are disregarded. This means that such arrears are no longer deducted from the Funeral Payment award.</p> answering member constituency Thornbury and Yate answering member printed Steve Webb question first answered 13/01/2015 11:21:37 answering member 220 label Biography information for Steve Webb
	tabling member	411 label Biography information for Mr Barry Sheerman

172277

	registered interest
	date	06/01/2015
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	HM Coastguard: Belfast
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, how many times the Maritime Rescue Co-ordination Centre at Belfast was staffed at below risk-assessed levels in December 2014.
	tabling member constituency	North Ayrshire and Arran
	tabling member printed	Katy Clark
	uin	219846
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>Where there are specific issues at a Maritime Rescue Coordination Centre (MRCC), Her Majesty’s Coastguard uses the current long established pairing arrangements between MRCCs. This enables each MRCC to be connected to at least one other MRCC which is available to provide mutual support.</p><p> </p><p>These historic risk assessed watch level assessments at MRCCs err strongly on the side of caution. As each MRCC joins the evolving national network the number of Coastguards at any of the individual centres becomes less significant. The flexibility of the new arrangements means that it is more important to consider the number of Coastguards available on the growing network.</p><p> </p><p>Based on the risk assessment which characterised the previous model, during December 2014 Belfast MRCC was staffed below risk assessed levels on 23 occasions out of 62 shifts and Stornoway was staffed below risk assessed levels on 41 occasions out of 62 shifts.</p><p> </p><p>During 2014 the MRCCs at Belfast and Stornoway were staffed below risk assessed levels at the same time 126 occasions out of 730 shifts during 2014.</p><p> </p><p>I have asked for a fresh appraisal of the relationship between the available levels of resource and need in the light of the benefit of the new structure.</p> answering member constituency South Holland and The Deepings answering member printed Mr John Hayes grouped question UIN 219848 219849 question first answered 13/01/2015 11:27:16 answering member 350 label Biography information for Sir John Hayes
	tabling member	1590 label Biography information for Baroness Clark of Kilwinning

172270

	registered interest
	date	06/01/2015
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	HM Coastguard
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, how many times the Maritime Rescue Co-ordination Centres at Belfast and Stornoway were staffed at below risk-assessed levels at the same time in 2014.
	tabling member constituency	North Ayrshire and Arran
	tabling member printed	Katy Clark
	uin	219848
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>Where there are specific issues at a Maritime Rescue Coordination Centre (MRCC), Her Majesty’s Coastguard uses the current long established pairing arrangements between MRCCs. This enables each MRCC to be connected to at least one other MRCC which is available to provide mutual support.</p><p> </p><p>These historic risk assessed watch level assessments at MRCCs err strongly on the side of caution. As each MRCC joins the evolving national network the number of Coastguards at any of the individual centres becomes less significant. The flexibility of the new arrangements means that it is more important to consider the number of Coastguards available on the growing network.</p><p> </p><p>Based on the risk assessment which characterised the previous model, during December 2014 Belfast MRCC was staffed below risk assessed levels on 23 occasions out of 62 shifts and Stornoway was staffed below risk assessed levels on 41 occasions out of 62 shifts.</p><p> </p><p>During 2014 the MRCCs at Belfast and Stornoway were staffed below risk assessed levels at the same time 126 occasions out of 730 shifts during 2014.</p><p> </p><p>I have asked for a fresh appraisal of the relationship between the available levels of resource and need in the light of the benefit of the new structure.</p> answering member constituency South Holland and The Deepings answering member printed Mr John Hayes grouped question UIN 219846 219849 question first answered 13/01/2015 11:27:16 answering member 350 label Biography information for Sir John Hayes
	tabling member	1590 label Biography information for Baroness Clark of Kilwinning

172242

	registered interest
	date	06/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Asthma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent discussions he has had with the Royal Colleges and the Asthma UK Centre for Applied Research about appropriate dosages for treatment of asthma.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	219788
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>We have had no such discussions.</p><p> </p><p><strong> </strong></p><p> </p><p>Prescribing decisions are a matter for clinicians based on their patients’ individual clinical needs and taking relevant advice from sources such as the British National Formulary, the National Institute for Health and Care Excellence, specialty association publications and any local prescribing policies.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 13/01/2015 11:18:09 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

172234

	registered interest
	date	06/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Innovative Medicines and Medical Technology Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to his announcement on 20 November 2014 of an Innovative Medicines and MedTech Review, how the independent organisation that will run the review will be selected; and what the criteria for the selection will be.
	tabling member constituency	Hartlepool
	tabling member printed	Mr Iain Wright
	uin	219834
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>I refer the hon. Member to the Written Ministerial Statement that I made on 20 November 2014, Official Report, column 14WS. The review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology will consider how to speed up access for National Health Service patients to cost-effective new diagnostics, medicines and devices.</p><p> </p><p> </p><p> </p><p>The Government is working to establish the formal terms of reference for the review. These will be published in due course. The exact structure of the review is currently being considered and, as appropriate, procurements will be through standard departmental procurement processes.</p><p> </p><p> </p><p> </p><p>The review will set out both short and long-term options for action by Government and relevant bodies — including the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency and NHS England. Officials are already working with these bodies and will continue to do so as the review progresses.</p><p> </p><p> </p><p> </p><p>The review will take into account a wide range of evidence to draw up its recommendations. We anticipate an initial report before the autumn.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 219835 219836 219837 question first answered 13/01/2015 11:15:25 answering member 4020 label Biography information for George Freeman
	tabling member	1478 label Biography information for Mr Iain Wright

172223

	registered interest
	date	06/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Innovative Medicines and Medical Technology Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to his announcement on 20 November 2014 of an Innovative Medicines and MedTech Review, if he will ensure that the review will take into consideration the conclusions of NICE following its consideration of responses to the Value-Based Assessment consultation.
	tabling member constituency	Hartlepool
	tabling member printed	Mr Iain Wright
	uin	219837
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>I refer the hon. Member to the Written Ministerial Statement that I made on 20 November 2014, Official Report, column 14WS. The review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology will consider how to speed up access for National Health Service patients to cost-effective new diagnostics, medicines and devices.</p><p> </p><p> </p><p> </p><p>The Government is working to establish the formal terms of reference for the review. These will be published in due course. The exact structure of the review is currently being considered and, as appropriate, procurements will be through standard departmental procurement processes.</p><p> </p><p> </p><p> </p><p>The review will set out both short and long-term options for action by Government and relevant bodies — including the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency and NHS England. Officials are already working with these bodies and will continue to do so as the review progresses.</p><p> </p><p> </p><p> </p><p>The review will take into account a wide range of evidence to draw up its recommendations. We anticipate an initial report before the autumn.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 219834 219835 219836 question first answered 13/01/2015 11:15:26 answering member 4020 label Biography information for George Freeman
	tabling member	1478 label Biography information for Mr Iain Wright

172222

	registered interest
	date	06/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Innovative Medicines and Medical Technology Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to his announcement on 20 November 2014 of an Innovative Medicines and MedTech Review, launched on 20 November 2014, what the formal terms of reference are for the review and what the deadline is for the review to report.
	tabling member constituency	Hartlepool
	tabling member printed	Mr Iain Wright
	uin	219836
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>I refer the hon. Member to the Written Ministerial Statement that I made on 20 November 2014, Official Report, column 14WS. The review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology will consider how to speed up access for National Health Service patients to cost-effective new diagnostics, medicines and devices.</p><p> </p><p> </p><p> </p><p>The Government is working to establish the formal terms of reference for the review. These will be published in due course. The exact structure of the review is currently being considered and, as appropriate, procurements will be through standard departmental procurement processes.</p><p> </p><p> </p><p> </p><p>The review will set out both short and long-term options for action by Government and relevant bodies — including the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency and NHS England. Officials are already working with these bodies and will continue to do so as the review progresses.</p><p> </p><p> </p><p> </p><p>The review will take into account a wide range of evidence to draw up its recommendations. We anticipate an initial report before the autumn.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 219834 219835 219837 question first answered 13/01/2015 11:15:26 answering member 4020 label Biography information for George Freeman
	tabling member	1478 label Biography information for Mr Iain Wright

172233

	registered interest
	date	06/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Innovative Medicines and Medical Technology Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to his announcement on 20 November 2014 of an Innovative Medicines and MedTech Review, whether the review will take into account the ongoing Innovation, Health and Wealth refresh.
	tabling member constituency	Hartlepool
	tabling member printed	Mr Iain Wright
	uin	219835
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>I refer the hon. Member to the Written Ministerial Statement that I made on 20 November 2014, Official Report, column 14WS. The review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology will consider how to speed up access for National Health Service patients to cost-effective new diagnostics, medicines and devices.</p><p> </p><p> </p><p> </p><p>The Government is working to establish the formal terms of reference for the review. These will be published in due course. The exact structure of the review is currently being considered and, as appropriate, procurements will be through standard departmental procurement processes.</p><p> </p><p> </p><p> </p><p>The review will set out both short and long-term options for action by Government and relevant bodies — including the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency and NHS England. Officials are already working with these bodies and will continue to do so as the review progresses.</p><p> </p><p> </p><p> </p><p>The review will take into account a wide range of evidence to draw up its recommendations. We anticipate an initial report before the autumn.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 219834 219836 219837 question first answered 13/01/2015 11:15:26 answering member 4020 label Biography information for George Freeman
	tabling member	1478 label Biography information for Mr Iain Wright

172284

	registered interest
	date	06/01/2015
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Level Crossings: Accidents
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what steps his Department is taking to reduce the number of fatalities at level-crossings.
	tabling member constituency	Clacton
	tabling member printed	Mr Douglas Carswell
	uin	219803
	answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>We must not be complacent about level crossing safety. An industry safety framework is in place to manage risks.</p><p> </p><p>As the relevant safety duty holder, Network Rail is best placed to assess the risks at level crossings and ensure that the most appropriate infrastructure is in place given local circumstances.</p><p> </p><p>Having already reduced risk significantly across the network, the company has set further challenging targets for risk reduction at level crossings by 2019. The Department is supporting this work through a dedicated £109 million ring-fenced fund which aims to close around a further 500 level crossings and improve safety at hundreds more of the highest risk crossings.</p> answering member constituency Devizes answering member printed Claire Perry question first answered 13/01/2015 11:24:54 answering member 3974 label Biography information for Claire Perry
	tabling member	1527 label Biography information for Mr Douglas Carswell